Basal cell carcinoma: Identification and treatment of the high-risk patient

Dermatologic Surgery

Volumn 22, Issue 3, 1996, Pages 255-261

  Randle, Henry W ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CHEMOSURGERY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; METASTASIS; PATIENT SELECTION; PRIORITY JOURNAL;

EID: 0029917721     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1996.tb00316.x     Document Type: Article

References (44)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8.
2. Broders AC. Basal-cell epithelioma. JAMA 1919;72:856-60.
3. Chuang TY, Popescu A, Su WP, et al Basal cell carcinoma: a population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 1990;22:413-7.
4. Jacob A. Observations respecting an ulcer of peculiar character, which attacks the eyelids and other parts of the face. Dublin Hospital Reports and Communications in Medicine and Surgery 1827;4:232-9.
5. Lo JS, Snow SN, Reizner GT, et al. Metastatic basal cell carcinoma. Report of twelve cases with a review of the literature. J Am Acad Dermatol 1991;24:715-9.
6. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part I. Overview. J Dermatol Surg Oncol 1991;17:713-8.
7. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 2. Curettage-electrodesiccation. J Dermatol Surg Oncol 1991;17:720-6.
8. Silverman MK, Kopf AW, Bart RS, et al. Recurrence rates of treated basal cell carcinomas. Part 3. Surgical excision. J Dermatol Surg Oncol 1992;18:471-6.
9. Silverman MK, Kopf AW, Gladstein AH, et al. Recurrence rates of treated basal cell carcinomas. Part 4. X-ray therapy. J Dermatol Surg Oncol 1992,18:549-54.
10. Roenigk R, Ratz JL, Bailin PL, et al. Trends in the presentation and treatment of basal cell carcinomas. J Dermatol Surg Oncol 1986; 12:860-5.
11. Rowe DE, Carroll RJ, Day CL, Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-28.
12. Rowe DE, Carroll RJ, Day CL, Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424-31.
13. Randle HW, Roenigk RK. Characteristics of giant basal cell carcinoma In: Roenigk RK, Roenigk HH, Jr, eds. Surgical Dermatology: Advances in Current Practice. St. Louis:Mosby, 1993;93-100.
14. Randle HW, Roenigk RK, Brodland DG. Giant basal cell carcinoma (T3). Who is at risk? Cancer 1993;72:1624-30.
15. Roenigk RK, Roenigk HH. Current surgical management of skin cancer in dermatology. J Dermatol Surg Oncol 1990;16:136-51.
16. Mohs FE: Chemosurgery: Microscopically Controlled Surgery for Skin Cancer. Springfield, IL: Charles C. Thomas, 1978.
17. Wade TR, Ackerman AB. The many faces of basal-cell carcinoma. J Dermatol Surg Oncol 1978;4:23-8.
18. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992;327:1649-62.
19. Lang PG, Jr, Maize JC: Histologic evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol 1986; 14:186-96.
20. Sexton M, Jones DB, Maloney ME: Histologic pattern analysis of basal cell carcinoma: study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990;23:1118-26
21. Rigel DS, Robins P, Friedman RJ. Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score. J Dermatol Surg Oncol 1981;7:807-10.
22. American Joint Committee on Cancer. Manual for Staging of Cancer, third ed. Philadelphia. JB Lippincott, 1988.
23. Jackson R. Unusual appearances of cancers in the skin. J Dermatol Surg Oncol 1981;7:159-63.
24. Braun-Falco O, Plewig G, Wolff HH, et al. Dermatology. Berlin: Springer-Verlag, 1991:1020.
25. Leffell DJ, Headington JT, Wong DS, et al. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol 1991;127: 1663-7.
26. Breuninger H, Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol 1991;17:574-8.
27. Wilder RB, Shimm DS, Kittelson JM, et al. Recurrent basal cell carcinoma treated with radiation therapy. Arch Dermatol 1991; 127:1668-72.
28. Smith SP, Foley EH, Grande DJ. Use of Mohs micrographic surgery to establish quantitative proof of heightened tumor spread in basal cell carcinoma recurrent following radiotherapy. J Dermatol Surg Oncol 1990;16:1012-6.
29. Dixon AY, Lee SH, McGregor DH. Histologic evolution of basal cell carcinoma recurrence. Am J Dermatopathol 1991;13:241-7.
30. Barsky SH, Grossman DA, Bhuta S. Desmoplastic basal cell carcinomas possess unique basement-membrane-degrading properties. J Invest Dermatol 1987;88:324-9.
31. Freeman RG. Histopathologic considerations in the management of skin cancer. J Dermatol Surg 1976;2:215-21.
32. Salasche SJ, Amonette RA. Morpheaform basal-cell epitheliomas: a study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol 1981;7:387-394.
33. Rizovsky R, Bourlond A, Mairesse M, et al. Epithelioma basocellulaire etendu de la nuque. Arch Belges Dermatol 1974;30:263-8.
34. Blewitt RW. Why does basal cell carcinoma metastasize so rarely? Int J Dermatol 1980;19:144-6.
35. Weinstock MA, Bogaars HA, Ashley M, et al. Non-melanoma skin cancer mortality: a population-based study. Arch Dermatol 1991; 127:1194-7.
36. Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987;123:340-4.
37. Lang PG Jr, Maize JC. Basal cell carcinoma. In: Friedman RJ, Rigel DS, Kopf AW, et al eds. Cancer of the Skin. Philadelphia: WB Saunders, 1991;35-73.
38. Robins P, Albom MJ. Recurrent basal cell carcinoma in young women. J Dermatol Surg Oncol 1975;1:49-51.
39. Whitaker DC. Unresectable primary facial curettage carcinoma. J Dermatol Surg Oncol 1992;18:125-9.
40. Robinson JK. Risk of developing another basal cell carcinoma: a 5-year prospective study. Cancer 1987;60:118-20.
41. Schreiber MM: The risk of developing another skin cancer. In: Roenigk RK, Roenigk HH, Jr eds. Surgical Dermatology: Advances in Current Practice. St. Louis: Mosby, 1993;16:177-80.
42. Peck G, DiGiovanna JJ, Kraemer KH, et al. Treatment and prevention of basal cell carcinoma with oral insotretinoin. In: Roenigk RK, Roenigk HH, Jr eds. Surgical Dermatology: Advances in Current Practice. St. Louis: Mosby, 1993;155-63.
43. Edwards L, Tucker SB, Perednia D, et al. The effect of an intralesional sustained-release formulation of Interferon alfa-2b on basal cell carcinomas. Arch Dermatol 1990;126:1029-1032.
44. Greenway HT. Interferon for skin cancer. In: Roenigk RK, Roenigk HH, Jr, eds: Surgical Dermatology: Advances in Current Practice. St. Louis: Mosby 1993;165-76.